Henry I. Miller


Henry I. Miller, MS, MD, was the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution. His research focused on public policy toward science and technology, encompassing a number of areas, including pharmaceutical development, genetic engineering in agriculture, models for regulatory reform, and the emergence of new viral diseases.

Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner and the founding director of the FDA's Office of Biotechnology. During his government service, Miller participated frequently on various expert and policy panels as a representative of the FDA or the US government. As a government official, Miller received numerous awards and citations.

During his time at the Hoover Institution, Miller has become well known not only for his contributions to scholarly journals but also for his articles and books that make science, medicine, and technology accessible. His work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View; To America's Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Miller has published extensively in a wide spectrum of scholarly journals and popular publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, the Guardian, Defining Ideas, and the Financial Times. He was a regulator contributor to Forbes.com and frequently appeared on the nationally syndicated radio programs of John Batchelor and Lars Larson.

Miller was selected by the editors of Nature Biotechnology as one of the people who had made the "most significant contributions" to biotechnology during the previous decade. He serves on numerous editorial boards.

Filter By:



Recent Commentary

this is an image

Federalize Vaccine Production? We’d Be Taking a Shot in the Dark

by Henry I. Miller, Sam Kazmanvia Hoover Digest
Tuesday, April 30, 2002

Since the anthrax scare last fall, there have been calls for the federal government to set up a National Vaccine Authority. Hoover fellow Henry I. Miller and Sam Kazman explain why that would be a mistake—with deadly consequences.

The New Normalcy

by Henry I. Miller, Sherri Ferrisvia Hoover Digest
Wednesday, January 30, 2002

Learning how to live in a newly dangerous world. By Hoover fellow Henry I. Miller and Sherri Ferris.

Analysis and Commentary

Regulation Is the Biggest Pest of All

by Henry I. Millervia Hoover Daily Report
Monday, December 31, 2001

"genetic resistance is where we want to go." But this definitive solution has been made hugely expensive and impractical by regulatory obstacles erected by the Environmental Protection Agency (EPA).

The Bush Administration Deals a Blow to Biotechnology—and to Itself

by Henry I. Millervia Hoover Digest
Tuesday, October 30, 2001

Scientists worldwide agree that adding genes to plants doesn’t make them dangerous either to the environment or for human consumption. Would someone please tell that to the EPA? By Hoover fellow Henry I. Miller.

The Perils of Precaution

by Henry I. Miller, Gregory Conkovia Policy Review
Friday, June 1, 2001

Why Regulators' "Precautionary Principle" Is Doing More Harm Than Good

Analysis and Commentary

Americans Are Dying for FDA Reform

by Henry I. Millervia Hoover Daily Report
Monday, April 9, 2001

Drug development in this country is more lengthy and expensive than anywhere in the world.

Analysis and Commentary

Environmental Protection, in Name Only

by Henry I. Millervia Hoover Daily Report
Monday, December 18, 2000

Regulation by the Environmental Protection Agency (EPA) has been criticized for being inefficient and unscientific.


The Greening of U.S. Foreign Policy

via Hoover Institution Press
Friday, November 3, 2000

In 1996 the U.S. government announced an increased emphasis on environmental issues in its foreign affairs. Since then "green" foreign policy has become a threat to national sovereignty without improving environmental quality. This collection of essays takes a hard look at how environmental concerns have come to help determine U.S. foreign policy—and the dangers that this poses.

First Do No Harm

by Henry I. Millervia Hoover Digest
Monday, October 30, 2000

The overzealous policies of the Food and Drug Administration have pushed the time and costs of drug development to stratospheric levels. It’s time for a sweeping reform. By Hoover fellow Henry I. Miller.

Death by Dietary Supplement

by Henry I. Miller, David Longtinvia Policy Review
Tuesday, August 1, 2000

How to regulate a booming industry